PollockSSwamyMRTremblayESShenL.Acanthosis nigricans in the pediatric population: a narrative review of the current approach to management in primary care. Pediatr Med. 2022;5:42-42. doi:10.21037/pm-21-70
2.
KaradağASYouYDanartiRAl-KhuzaeiSChenW.Acanthosis nigricans and the metabolic syndrome. Clin Dermatol. 2018;36(1):48-53. doi:10.1016/j.clindermatol.2017.09.008
3.
ChangJEChoiMS.A molecular perspective on the potential benefits of metformin for the treatment of inflammatory skin disorders. Int J Mol Sci. 2020;21(23):8960. doi:10.3390/ijms21238960
RomoABenavidesS.Treatment options in insulin resistance obesity-related acanthosis nigricans. Ann Pharmacother. 2008;42(7):1090-1094. doi:10.1345/aph.1K446
6.
BöhmMLugerTAMetzeD.Treatment of mixed-type acanthosis nigricans with topical calcipotriol. Br J Dermatol. 1998;139(5):932-934. doi:10.1046/j.1365-2133.1998.02538.x
7.
GregoriouSAnyfandakisVKontoleonPChristofidouERigopoulosDKontochristopoulosG.Acanthosis nigricans associated with primary hypogonadism: successful treatment with topical calcipotriol. J Dermatolog Treat. 2008;19(6):373-375. doi:10.1080/09546630802050506
8.
ZayedASobhiRMAbdel HalimDM.Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study. J Dermatolog Treat. 2014;25(3):223-225. doi:10.3109/09546634.2012.674194
